Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment.
Publication
, Journal Article
Raake, PW; Koch, WJ; Most, P
Published in: Pharmacogenomics
March 2011
Duke Scholars
Published In
Pharmacogenomics
DOI
EISSN
1744-8042
Publication Date
March 2011
Volume
12
Issue
3
Start / End Page
295 / 297
Location
England
Related Subject Headings
- Signal Transduction
- Receptors, Adrenergic, beta
- Polymorphism, Genetic
- Pharmacology & Pharmacy
- Leucine
- Humans
- Heart Failure
- G-Protein-Coupled Receptor Kinases
- G-Protein-Coupled Receptor Kinase 5
- Drug Resistance
Citation
APA
Chicago
ICMJE
MLA
NLM
Raake, P. W., Koch, W. J., & Most, P. (2011). Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment. Pharmacogenomics, 12(3), 295–297. https://doi.org/10.2217/pgs.11.13
Raake, Philip W., Walter J. Koch, and Patrick Most. “Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment.” Pharmacogenomics 12, no. 3 (March 2011): 295–97. https://doi.org/10.2217/pgs.11.13.
Raake PW, Koch WJ, Most P. Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment. Pharmacogenomics. 2011 Mar;12(3):295–7.
Raake, Philip W., et al. “Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment.” Pharmacogenomics, vol. 12, no. 3, Mar. 2011, pp. 295–97. Pubmed, doi:10.2217/pgs.11.13.
Raake PW, Koch WJ, Most P. Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment. Pharmacogenomics. 2011 Mar;12(3):295–297.
Published In
Pharmacogenomics
DOI
EISSN
1744-8042
Publication Date
March 2011
Volume
12
Issue
3
Start / End Page
295 / 297
Location
England
Related Subject Headings
- Signal Transduction
- Receptors, Adrenergic, beta
- Polymorphism, Genetic
- Pharmacology & Pharmacy
- Leucine
- Humans
- Heart Failure
- G-Protein-Coupled Receptor Kinases
- G-Protein-Coupled Receptor Kinase 5
- Drug Resistance